Skip to content

    ADMA BIOLOGICS (ADMA) stock price & financials

    View ADMA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance45.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $119.84M
    $117.55M
    $114.80M
    $121.98M
    $134.22M
    +12.0%
    $139.16M
    +18.4%
    $114.49M
    -0.3%
    $124.39M
    +2.0%
    Strengthening
    Operating Profit
    $39.64M
    $38.32M
    $34.88M
    $42.80M
    $51.01M
    +28.7%
    $62.75M
    +63.7%
    $58.27M
    +67.1%
    $52.45M
    +22.5%
    Strengthening
    Net Profit
    $35.91M
    $111.90M
    $26.90M
    $34.22M
    $36.43M
    +1.4%
    $49.38M
    -55.9%
    $45.33M
    +68.5%
    $37.82M
    +10.5%
    Strengthening
    EPS
    $0.15
    $0.11
    $0.14
    $0.15
    +0.0%
    $0.19
    +72.7%
    $0.17
    +21.4%
    Strengthening
    Other Income
    -$2.89M
    -$3.61M
    -$1.43M
    -$2.70M
    -$3.50M
    -21.0%
    -$1.16M
    +67.9%
    -$1.15M
    +19.8%
    -$2.21M
    +18.3%
    Strengthening
    Interest
    $3.50M
    $2.88M
    $1.98M
    $1.83M
    $1.68M
    -52.1%
    $1.63M
    -43.5%
    $2.10M
    +6.3%
    $3.42M
    +86.7%
    Strengthening
    Depreciation
    Profit before Tax
    $36.75M
    $34.71M
    $33.45M
    $40.10M
    $47.52M
    +29.3%
    $61.59M
    +77.4%
    $57.13M
    +70.8%
    $50.24M
    +25.3%
    Strengthening
    MarginsOPM
    33.1%
    32.6%
    30.4%
    35.1%
    38.0%
    +14.9%
    45.1%
    +38.3%
    50.9%
    +67.5%
    42.2%
    +20.2%
    Strengthening
    Tax
    2.3%
    -222.3%
    19.6%
    14.7%
    23.3%
    +918.8%
    19.8%
    20.6%
    +5.5%
    24.7%
    +68.6%
    Strengthening
    ReturnsROIC
    -45.8%
    -142.6%
    -34.3%
    -43.6%
    -46.4%
    -1.4%
    -62.9%
    +55.9%
    -57.8%
    -68.5%
    -48.2%
    -10.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$26.75M$26.75M$55.92M$51.09M$86.52M$51.35M$103.15M$87.63M$136.02M
    Short-Term Investments
    Total Current Assets$44.53M$85.82M$153.74M$208.73M$270.40M$257.01M$331.41M$466.51M$528.20M
    Net PP&E$30.12M$32.99M$45.85M$58.20M$68.75M$63.47M$63.34M$71.71M$72.81M
    Goodwill$3.53M$3.53M$3.53M$3.53M$3.53M$3.53M$3.53M$3.53M$3.53M
    Intangibles$4.00M$3.16M$2.44M$1.73M$1.01M$499.0K$460.0K$632.0K$575.0K
    Total Assets$88.88M$127.09M$207.67M$276.25M$348.46M$329.18M$488.68M$624.24M$684.21M
    LiabilitiesTotal Current Liabilities$9.63M$14.03M$19.95M$30.38M$39.27M$49.81M$55.54M$69.54M$75.76M
    Short-Term Debt$0$2.81M$3.75M
    Long-Term Debt$2.76M$0$72.34M$69.33M$192.84M
    Long-Term Leases$4.33M$7.46M$10.70M$9.78M$8.56M$6.65M$6.07M
    Total Liabilities$69.11M$100.90M$119.42M$135.08M$196.49M$193.98M$139.66M$146.92M$276.00M
    EquityCommon Stock & APIC$4.6K$5.9K$10.5K$19.6K$22.0K$23.0K$24.0K$24.0K$24.0K
    Retained Earnings-$216.44M-$264.72M-$340.47M-$412.11M-$478.02M-$506.26M-$308.58M-$161.65M-$78.50M
    Total Equity$19.77M$26.19M$88.25M$141.17M$151.97M$135.21M$349.02M$477.32M$408.21M
    HighlightsNet Cash / (Debt)$30.81M$15.49M-$60.57M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$62.68M-$76.19M-$102.00M-$112.37M-$59.51M$8.80M$118.67M$50.40M$136.72M
    Cash from Investing-$2.10M-$3.81M-$12.72M-$13.51M-$13.91M-$4.98M-$8.57M-$21.89M-$14.50M
    Cash from Financing$42.92M$80.00M$143.90M$121.05M$108.85M-$38.99M-$58.30M-$44.02M-$76.49M
    SummaryCapital Expenditure-$2.10M-$3.81M-$12.73M-$13.51M-$13.91M-$4.77M-$8.23M-$22.57M-$20.25M
    Free Cash Flow-$64.77M-$80.01M-$114.73M-$125.88M-$73.42M$4.03M$110.45M$27.82M$116.47M
    FCF Margin-381.4%-272.6%-271.7%-155.5%-47.6%1.6%25.9%5.5%22.7%

    Ratios